Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Plos One|November 23, 2017
Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitusMasaki Miyazawa, Hajime Takatori, Tetsuro Shimakami, et al.Clinical Journal of Gastroenterology|June 29, 2020
Tumor lysis syndrome in a patient with metastatic melanoma treated with nivolumabSaiho Sugimoto, Takeshi Terashima, Tatsuya Yamashita, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Impact of the revised Japanese indication criteria for deceased donor liver transplantation on liver cirrhotic patients of Child-Pugh classification B with hepatocellular carcinomaAkihiro Seki, Tatsuya Yamashita, Takeshi Terashima, et al.Biochemical and Biophysical Research Communications|July 7, 2023
Aldo-keto reductase family 1 member B10 is regulated by nucleos(t)ide analogues for chronic hepatitis BNoriaki Orita, Kazunori Kawaguchi, Masao Honda, et al.Medicine|August 16, 2021
Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver diseaseKazunori Kawaguchi, Yoshio Sakai, Takeshi Terashima, et al.Plos Pathogens|December 17, 2025
Netrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infectionYing Wang, Kazuhisa Murai, Atsuya Ishida, et al.Gastroenterology|April 5, 2011
Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis CMasao Honda, Kenji Takehana, Akito Sakai, et al.The Journal of Biological Chemistry|August 5, 2020
Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitorsGeorg Dultz, Tetsuro Shimakami, Markus Schneider, et al.BMC Gastroenterology|December 18, 2019
Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patientsTakehiro Hayashi, Hajime Takatori, Rika Horii, et al.Cellular and Molecular Gastroenterology and Hepatology|March 15, 2020
Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular CarcinomaTomomi Hashiba, Taro Yamashita, Hikari Okada, et al.Pageof 12